
ARVN
Healthcare · Biotechnology · $446.6M market cap
$6.82-0.05 (-0.7%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +9.7% over 90 days · 30-day revisions 9 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2026 | Before the open | -0.80 | -0.82 | -2.5% |
| Aug 4, 2026 | Before the open | -0.24 | 2.58 | +1175.0% |
| May 12, 2026 | Time not confirmed | -0.96 | -0.90 | +6.6% |
| Feb 24, 2026 | Before the open | -0.57 | -1.10 | -93.0% |
| Nov 5, 2025 | Before the open | -0.75 | -0.48 | +36.0% |
| Aug 6, 2025 | Before the open | -0.89 | -0.84 | +5.6% |
| May 1, 2025 | Before the open | -0.97 | 1.14 | +217.5% |
| Feb 11, 2025 | Before the open | -0.96 | -0.63 | +34.4% |
| Oct 30, 2024 | Before the open | -0.87 | -0.68 | +21.8% |
| Jul 30, 2024 | Before the open | -0.59 | -0.49 | +16.9% |
| May 7, 2024 | Before the open | -1.38 | -0.97 | +29.7% |
| Feb 27, 2024 | Before the open | -1.27 | -2.53 | -99.2% |
| Nov 7, 2023 | Before the open | -1.58 | -1.18 |
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical…
| +25.3% |
| Aug 8, 2023 | Before the open | -1.61 | -1.25 | +22.4% |
| May 5, 2023 | Before the open | -1.49 | -1.54 | -3.4% |
| Feb 23, 2023 | Before the open | -1.22 | -1.56 | -27.9% |
| Nov 8, 2022 | Before the open | -1.07 | -1.24 | -15.9% |
| Aug 4, 2022 | Before the open | -1.04 | -1.32 | -26.9% |
| May 5, 2022 | Before the open | -0.91 | -1.20 | -31.9% |
| Feb 28, 2022 | Before the open | -0.79 | -1.00 | -26.6% |
| Nov 3, 2021 | Before the open | 2.13 | -0.94 | -144.1% |
| Aug 5, 2021 | Before the open | -0.86 | -1.03 | -19.8% |
| May 4, 2021 | Before the open | -0.81 | -0.84 | -3.7% |
| Mar 1, 2021 | Before the open | -0.78 | -0.99 | -26.9% |
| Nov 5, 2020 | Before the open | -0.66 | -0.79 | -19.7% |
| Aug 4, 2020 | Before the open | -0.59 | -0.65 | -10.2% |
| Apr 28, 2020 | Before the open | -0.59 | -0.56 | +5.1% |
| Mar 16, 2020 | Before the open | -0.56 | -0.56 | 0.0% |
| Nov 4, 2019 | After the close | -0.52 | -0.54 | -3.8% |
| Aug 5, 2019 | Before the open | -0.43 | -0.55 | -27.9% |
| May 8, 2019 | Before the open | -0.47 | -0.46 | +2.1% |
| Mar 26, 2019 | Before the open | -0.61 | -0.52 | +14.8% |
| Nov 14, 2018 | Before the open | -0.28 | -0.57 | -103.6% |
| Sep 27, 2018 | After the close | 0.00 | -0.21 | — |
| Jun 22, 2018 | Time not confirmed | — | -0.92 | — |